Comments
Loading...

BioNTech

BNTXNASDAQ
Logo brought to you by Benzinga Data
$117.35
1.731.50%
Pre-Market: 8:47 AM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$300.00
Lowest Price Target1
$85.00
Consensus Price Target1
$149.65

BioNTech (NASDAQ:BNTX) Stock, Analyst Ratings, Price Targets, Forecasts

BioNTech SE has a consensus price target of $149.65 based on the ratings of 20 analysts. The high is $300 issued by Canaccord Genuity on April 5, 2022. The low is $85 issued by TD Cowen on August 6, 2024. The 3 most-recent analyst ratings were released by UBS, Jefferies, and JP Morgan on September 18, 2024, September 17, 2024, and September 16, 2024, respectively. With an average price target of $135.33 between UBS, Jefferies, and JP Morgan, there's an implied 15.32% upside for BioNTech SE from these most-recent analyst ratings.

Analyst Trends and Forecast
1
May
0
0
0
0
Jun
1
Aug
2
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.2
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

UBS
Jefferies
JP Morgan
B of A Securities
HC Wainwright & Co.

1calculated from analyst ratings

Analyst Ratings for BioNTech

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for BioNTech (BNTX) stock?

A

The latest price target for BioNTech (NASDAQ:BNTX) was reported by UBS on September 18, 2024. The analyst firm set a price target for $131.00 expecting BNTX to rise to within 12 months (a possible 11.63% upside). 40 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for BioNTech (BNTX)?

A

The latest analyst rating for BioNTech (NASDAQ:BNTX) was provided by UBS, and BioNTech maintained their neutral rating.

Q

When was the last upgrade for BioNTech (BNTX)?

A

The last upgrade for BioNTech SE happened on September 17, 2024 when Jefferies raised their price target to $150. Jefferies previously had a hold for BioNTech SE.

Q

When was the last downgrade for BioNTech (BNTX)?

A

The last downgrade for BioNTech SE happened on December 1, 2023 when JP Morgan changed their price target from $106 to $99 for BioNTech SE.

Q

When is the next analyst rating going to be posted or updated for BioNTech (BNTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioNTech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioNTech was filed on September 18, 2024 so you should expect the next rating to be made available sometime around September 18, 2025.

Q

Is the Analyst Rating BioNTech (BNTX) correct?

A

While ratings are subjective and will change, the latest BioNTech (BNTX) rating was a maintained with a price target of $97.00 to $131.00. The current price BioNTech (BNTX) is trading at is $117.35, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch